Table 3.
Study design, characteristics, and summary of outcomes.
| Author, country, year | Design of randomized controlled trial | Participants | Intervention, number (male/female), daily dose | Control, number (male/female), daily dose | Duration | Effect | Risk of bias |
|---|---|---|---|---|---|---|---|
| McGeoch et al. (29) United Kingdom | Crossover | Type 2 diabetes, 40–75 years | Oat-based product, 27 (18/9), 60–100 g | Standard diet, 27 (18/9), NA | 8 weeks | ↔ CRP, IL-18, Adiponectin | Some concerns |
| Koenig et al. (27) United States | Parallel | Young female aged 18–30 | Avenanthramides in oat cookies, 8 (0/8), 9.2 mg | Avenanthramides; oat flour cookies, 8 (0/8), 0.4 mg | 8 weeks | ↓ NRB, IL-6, TNF-α, CRP ↔ IL-1b | Low risk |
| Koenig et al. (16) United States | Parallel | Female aged 50–80 | Avenanthramides in oat cookies, 8 (0/8), 9.2 mg | Avenanthramides; oat flour cookies, 8 (0/8), 0.4 mg | 8 weeks | ↓ IL-1B, NRB, CRP ↔ IL-6, TNF-α | Low risk |
| Zhang T et al. (34) United States | Parallel | Healthy subjects, 23.0 ± 1.2 years | Avenanthramides in oat cookies, 12 (NA), 20.6 mg | Avenanthramides; oat flour cookies, 12 (NA), 0 mg | 8 weeks | ↓ IL-1Ra, sVCAM-1, G-CSF, NRB ↔ IL-6, MCP-1, CK | High risk |
| Nieman et al. (17) United States | Parallel | Healthy male subjects | Oat β-glucan in beverage, 19 (19/0), 5.6 g/600 mL | Cornstarch in beverage, 17 (17/0), 600 mL | 14 days | ↔ IL-6, IL-10, IL-8, IL-1Ra | Some concerns |
| Tighe P et al. (33) United Kingdom | Parallel | Middle aged (40–65 y), healthy subjects | Oat cereals, 70 (36/34), 60–80 g | Whole-grain cereals, 73 (38/35), 90–120 g | 12 weeks | ↔ hs-CRP, IL-6 | Some concerns |
| Fazilaty et al. (26) Iran | Parallel | Multiple trauma, ≥18 years | Oat β-glucan, 20 (18/2), 3 g | Maltodextrin, 20 (18/2), 3 g | 21 days | ↑ IL-12 ↔ hs-CRP | Some concerns |
| Ma et al. (28) China | Parallel | Type 2 diabetes, 50–60 years | Organic naked oat with whole germ porridge, 65 (27/38), 50 g | Diet group, 61 (28/33), balance nutritional composition without oat | 30 days | ↔ hs-CRP | Some concerns |
| Organic naked oat with whole germ porridge, 65 (27/38), 100 g | Diet group, 61 (28/33), balanced nutritional composition without oat | 30 days | ↓ hs-CRP | ||||
| Ganda Mall et al. (31) Sweden | Parallel | Healthy subjects, ≥65 years | Oat β-glucan powder, 15 (9/6), 12 g | Maltodextrin powder, 17 (9/8), 12 g | 6 weeks | ↔ IFN-γ, IL-10, CRP, IL-1b, IL-2, IL-6, IL-8, TNF-α, IL-12p70 | Some concerns |
| Arabinoxylan powder, 17 (9/8), 12 g | 6 weeks | ↔ IFN-γ, IL-10, CRP, IL-1b, IL-2, IL-6, IL-8, TNF-α, IL-12p70 | |||||
| Sirtori et al. (37) Italy | Parallel | Moderate hypercholesterolemia | Oat fiber containing 25-28% β-glucan with casein bar, 22 (NA), 10.5 g | Cellulose with casein bar, 25 (10/15), 10 g | 4 weeks | ↔ Adiponectin, sICAM-1, IL-6, hs-CRP | High risk |
| Oat fiber containing 25-28% β-glucan with casein bar, 23 (NA), 10.5 g | Cellulose with casein bar, 25 (11/14), 10 g | 4 weeks | ↔ Adiponectin, sICAM-1, IL-6, hs-CRP | ||||
| Connolly et al. (35) United Kingdom | Crossover | Healthy subjects, 19–60 years | Whole grain oat granola, 30 (11/19), 45 g | Non-whole grain cereal, 30 (11/19), 45 g | 6 weeks | ↔ CRP, TNF-α, IL-6, Calprotectin, Ig A | Low risk |
| Xia et al. (39) China | Parallel | Healthy male, 19.7 ± 1.1 years | Oat protein beverage, 8 (8/0), 25 g | Maltodextrin beverage, 8 (8/0), 25 g | 19 days | ↓ CRP, IL-6 | Low risk |
| Thompson et al. (38) United States | Parallel | Healthy male, 18–30 years | β-Glucan (oat bran) powder, 9 (9/0), 3 g | Muffin mix powder, 11 (11/0), 3 g | 4 weeks | ↓ 24 h soreness score | High risk |
| Theuwissen et al. (18) Netherlands | Crossover | Mild hypercholesterolemia, 52 ± 11 years | Oat β-glucan in muesli, 30 (NA), 4.8 g | Wheat fiber in muesli, 30 (NA), 4.8 g | 4 weeks | ↔ TNF-α, IL-6, IL-8, hs-CRP | High risk |
| Pavadhgul P et al. (36) Thailand | Crossover | Hypercholesterolemia, 30–60 years | Oat porridge, 24 (NA), 70 g | Rice porridge, 24 (NA), 70 g | 4 weeks | ↓ hs-CRP, IL-6, IL-8, TNF-α, MCP-1 | High risk |
| Zhang et al. (44) United Kingdom | Crossover | Type 2 diabetes, 40–75 years | Oat-enriched diet (commercial product), 22 (NA), 131 g | Non-oat product (daily meal), 22 (NA), NA | 8 weeks | ↔ P-selectin, CRP, IL-18 | High risk |
| Sawicki CM et al. (41) United States | Crossover | Overweight or mildly obese, metabolically at-risk, 40–70 years | Whole oat flour muffins, 13 (8/5), 48 g | Refined wheat flour muffins, 13 (8/5), 48 g | 1 day | ↔ hs-CRP, IL-6, IL-8, TNF-α | Some concerns |
| Biörklund et al. (40) Sweden | Parallel | Healthy, but with mildly elevated serum cholesterol levels, 35–72 years | Oat β-glucan soup, 22 (NA), 4 g per 400 g soup | Placebo soup, 21 (NA), 0 g per 400 g soup | 5 weeks | ↔ hs-CRP | Some concerns |
| Sturtzel et al. (42) Austria | Parallel | Frail patients (57–98 years), who are geriatric hospital residents with multiple chronic diseases and require assistance for their daily life activities | Oat flakes (oat-bran product) blended into common daily meals, 15 (NA), 5.2 g | Ward's habitual diet, 15 (NA), NA | 12 weeks | ↓ CRP | Some concerns |
| Queenan et al. (32) United States | Parallel | Hypercholesterolemia, 22–65 years | Oat β-glucan powder in beverage, 35 (22/13), 6 g | Dextrose powder in beverage, 40 (28/12), 6 g | 6 weeks | ↔ CRP | Some concerns |
| Cugnet-Anceau et al. (30) France | Parallel | Type 2 diabetes, 30–75 years | Soup containing oat β-glucan, 29 (NA), 3.5 g in 400 g | Soup without oat β-glucan, 24 (NA), 0 g in 400 g | 11 weeks | ↔ CRP | Some concerns |
| Maki et al. (45) United States | Parallel | Overweight and obese adults | Whole-grain oat cereal, 77 (NA), 40 g (providing 3 g β-glucan) | Low-fiber breakfast/snack foods, 67 (NA), ~500 kcal | 12 weeks | ↔ hs-CRP | Some concerns |
| Wolever et al. (43) Canada | Parallel | Healthy subjects, 20–65 years | High-molecular-weight oat β-glucan-containing cereals, 81 (43/43), 3 g | Wheat bran-containing cereals, 87 (36/51), NA | 4 weeks | ↔ CRP | Some concerns |
| Medium-molecular-weight oat β-glucan-containing cereals, 67 (33/34), 4 g | 4 weeks | ↔ CRP | |||||
| Medium-molecular-weight oat β-glucan-containing cereals, 64 (27/37), 3 g | 4 weeks | ↔ CRP | |||||
| Low-molecular-weight oat β-glucan-containing cereals, 63 (22/41), 4 g | 4 weeks | ↔ CRP |
NA, not available; ↔, no significant change; ↓, significant decrease (p <0.05); ↑, significant increase (p < 0.05).